PREPARATION AND EVALUATION OF METOPROLOL SUCCINATE TABLET USING JACKFRUIT MUCILAGE

Main Article Content

Kapil Kumar
Dr. Vandana Arora Sethi
Ms. Savita Bhati

Keywords

Sustained release tablet, Metoprolol succinate, Jackfruit mucilage,, Wet granulation

Abstract

The aim of the current research work was to isolate and evaluate Jackfruit mucilage to develop metoprolol succinate tablets using varying concentration of jackfruit mucilage. Tablets containing 50mg drug were prepared by wet granulation method. Compatibility study was carried out by using FTIR and confirmed that no chemical interaction took place during entrapment process. Pre-compression parameters like Bulk density, Tapped density, Carr’s index, Hausner’s ratio, and angle of repose were evaluated and post-compression parameters like Friability, Hardness, Thickness, Diameter, Weight variation, Disintegration, and Drug content estimation and Dissolution were evaluated and the results were within the acceptable official limits. In-vitro drug release was carried out by using USP dissolution rate apparatus type- II using two different dissolution media (0.1 N HCl and phosphate buffer of pH 6.8). In- vitro drug release shows, as the concentration of jackfruit mucilage increases, drug release decreases. The drug release follows first order kinetics and mechanisms was found to be super case II. The stability studies were carried out for two months. In conclusion result suggested that formulation containing jackfruit mucilage delayed the drug release could therapeutically better than conventional dosage form leading to improved efficacy and better patient compliance

Abstract 202 | pdf Downloads 91

References

1. Gilbert S. Banker, Christopher T. Rhodes, Modern Pharmaceutics, 4th Edition, 121, 2005, Marcel Dekker, Inc, 501-514.
2. Thomas Wait-Yip Lee and Joseph R Robinson, Controlled Release Drug Delivery system, In the Science and Practice of Pharmacy, Volume 1, 20th edition, 2001, 903.
3. Yie W. Chein, Oral Drug Delivery System, Novel drug delivery Systems, volume 50, 2nd Edition, Marcel Dekker, Inc., 139-157.
4. Donald L. Wise, Hand Book of Pharmaceutical Controlled Release Technology, 2005, Marcel Dekker, Inc, 435-440.
5. Gwen M. Jantzen and Joseph R. Robinson, Sustained and controlled Release Drug Delivery System, In Modern Pharmaceutics, Marcel Dekker, Inc., 3rd edition, 1996, 582-593.
6. Li VHK, Robinson JR, Lee VHL, Design and Fabrication of oral Controlled Drug Delivery System, In Controlled Drug Delivery, Marcel Dekkar 1987, 2nd edition, 412.
7. Agis Kydonieus, Treatise on Controlled Drug Delivery, Marcel Dekker 1st Edition, 1992, 43-93.
8. S.P. Vyas, Roop. K. Khar, Controlled Drug Delivery Concept and Advances, 1st edition, 2002, 54-71.
9. Tabandeh H, Mortazavi S.A, Guilani T.B. Preparation of sustained-release matrix tablet of asprin with ethyl cellulose, eudragit RS100 and studying the release profiles and their sensitivity to tablet hardness. Iranian J Pharm Res 2003; 2: 201-06.
10. Shantveer V, Salger, L. S. Danki, Shivanand H, Abdul S. Preparation and evaluation of sustained release matrix tablets of Propranolol hydrochloride. Int J of Pharm and Bio Sci. 2010; 1(4):227-241.
11. Uddin M. Development of sustained release tablet of Valsartan. World J Pharm Sci 2015;3(5):1196-1205.
12. Vinith S , Sharma S, Khokra S.L, Sahu R.K.R, Jangde R, Singh J. Formulation, dev and evaluation of Pregabalin Sustained release matrix tablets. Der Pharmacia Lettre. 2011; 3(5):326-31.
13. Basavaraj, Someswara Rao B, Kulkarni S.K , Pramod P and Chetan S. Design and characterization of sustained release Aceclofenac matrix tablets containing tamarind seed polysaccharide. Asian J. Pharm Tech. 2011;1(1):17-21.
14. Rakesh P.P, Mehul H.P, Bhupendra G.P, Ashok H.B. Formulation and evaluation of sustained release matrix tablet of Tizanidine Hydrochloride by direct compression technique. e-J Sci & Tech (e-JST) 2011;6(1):69-81.
15. Avinash B, Gangurde. Preliminary characterization of Abelmoschus esculentus (L) pod mucilage as O/W type emulsifier. IJAPBC.2012:1(1);36-41.
16. Madhavi N, Sudhakar B, Ravikanth PV, Mohon K, Kolapalli RM. Formulation and Evaluation of Phenytoin Sodium Sustained Release Matrix Tablet. Bioequivalence and Bioavailability. J Bioequiv Availab. 2012; 4 (7):128-133.
17. Madhavi V, Parthiban P and Veera Anjaneyulu K: Formulation And Evaluation Of Lovastatin Controlled Release Tablets”. International Journal Of Pharmacy And Pharmaceutical Analysis. 2017;VOl -01(03):79-84
18. Maniruzzaman M, Slipper IJ, Vithani K, Douroumis D. Sustained release solid lipid matrices processed by hot-melt extrusion (HME). Colloids Surf B 2013;110:403-10.
19. Panchagnula R, Singh R and Ashokraj Y: In vitro evaluation of modified release formulations of nifedipine from Indian market. Indian Journal of Pharmaceutical Sciences 2007; 69(4). DOI- 10.4103/0250-474X.36944
20. Parikh K, P. Mundada1 and Krutika Sawant: Design and Optimization of Controlled Release Felbamate Tablets by D-optimal Mixture Design: In vitro-in vivo Evaluation. Indian J Pharm Sci 2019;81(1):71-81
21. Sahu S, Dangi R, Patidar R, Rukhsaar, Rathi J, Asati V, Formulation and evaluation of sustain released matrix tablet of atenolol, Journal of Drug Delivery and Therapeutics. 2019; 9(1):183-189
22. Sathoskar RS, S.D, Bhandarkar, Nimala N. Rege, Pharmacology and pharmacotherapeutics, 2009, Ninth edition, 884-891